Prognostic factors in breast cancer: Current and new predictors of metastasis

被引:179
作者
Hayes, DF
Isaacs, C
Stearns, V
机构
[1] Univ Michigan, Ctr Comprehens Canc, Breast Oncol Program, Ann Arbor, MI 48109 USA
[2] Georgetown Univ, Vincent T Lombardi Canc Res Ctr, Breast Canc Program, Washington, DC USA
关键词
breast cancer; prognostic factors; adjuvant systemic therapy; tumor marker utility grading system;
D O I
10.1023/A:1014778713034
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Decisions regarding the use of adjuvant therapy for breast cancer are strongly influenced by the risk of disease recurrence and death. These risks are now determined by, examining the currently recognized breast cancer prognostic factors, including clinical stage, axillary nodal status. tumor size and grade, hormone receptor status. and presence of lymphovascular involvement. Newer factors are being evaluated in an attempt to more precisely define disease-related prognosis. This paper provides an overview of issues that need to be considered when analyzing studies of prognostic factors as well as a review of the currently recognized and the newer candidate prognostic factors.
引用
收藏
页码:375 / 392
页数:18
相关论文
共 102 条
[51]  
Hui R, 2000, CLIN CANCER RES, V6, P2777
[52]  
HUTCHINS L, 1998, P AN M AM SOC CLIN, V17, pA1
[53]   New prognostic factors for breast cancer recurrence [J].
Isaacs, C ;
Stearns, V ;
Hayes, DF .
SEMINARS IN ONCOLOGY, 2001, 28 (01) :53-67
[54]   Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 [J].
Jänicke, F ;
Prechtl, A ;
Thomssen, C ;
Harbeck, N ;
Meisner, C ;
Untch, M ;
Sweep, CGJF ;
Selbmann, HK ;
Graeff, H ;
Schmitt, M .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (12) :913-920
[55]   The sentinel node in breast cancer - A multicenter validation study [J].
Krag, D ;
Weaver, D ;
Ashikaga, T ;
Moffat, F ;
Klimberg, VS ;
Shriver, C ;
Feldman, S ;
Kusminsky, R ;
Gadd, M ;
Kuhn, J ;
Harlow, S ;
Beitsch, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (14) :941-946
[56]  
Krajewski S, 1997, CLIN CANCER RES, V3, P199
[57]  
KRAJEWSKI S, 1995, CANCER RES, V55, P4471
[58]   Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer [J].
Lindley, C ;
Vasa, S ;
Sawyer, WT ;
Winer, EP .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) :1380-1387
[59]   HETEROGENEITY IN LI-FRAUMENI FAMILIES - P53 MUTATION ANALYSIS AND IMMUNOHISTOCHEMICAL STAINING [J].
MACGEOCH, C ;
TUMER, G ;
BOBROW, LG ;
BARNES, DM ;
BISHOP, DT ;
SPURR, NK .
JOURNAL OF MEDICAL GENETICS, 1995, 32 (03) :186-190
[60]  
MCGUIRE WL, 1992, NEW ENGL J MED, V326, P1756